Combined urethral and suprapubic catheter drainage improves post operative management after open simple prostatectomy without bladder irrigation

Table 1 Demographic and clinic characteristics of groups 1 and 2 patients

Reps	Group 1 (mean ± SD)	Group 2 (mean ± SD)	P value
Patients (n)	42	42
Age (yr)	65.7 (± 7.6)	64.8 (± 6.8)	0.598
Prostate volume (mL)	85.6 (± 49.1)	89.3 (± 42.1)	0.715
PSA (ng/mL)	15.3 (± 15.0)	12.6 (± 15.3)	0.417
Duration of surgery (min)	102.9 (± 18.8)	100.7 (± 14.9)	0.555
Blood transfusion (pints)	0.4 (± 0.6)	0.6 (± 0.9)	0.277
Clot retention episodes	0.8 (± 1.5)	3.5 (± 4.4)	0
Clot retention episodes requiring bladder syringing	0.4 (± 0.9)	2.6 (± 3.8)	0.001
Requirement for extra analgaesic	0.4 (± 0.5)	4.0 (± 1.5)	0
Change in haemoglobin (g/dL)	1.9 (± 1.2)	2.1 (± 1.1)	0.408
Duration of admission (d)	8.6 (± 1.2)	7.3 (± 0.6)	0

PSA: Prostate specific antigen.

Table 2 Overall complication rate and details of complications by Clavien Dindo grade observed in both groups n (%)

Complications	Clavien Dindo grade	Group 1	Group 2	Total	P value
Overall complications		14 (33.3)	15 (35.7)	29 (34.5)	0.5
Post prostatectomy (LUTS)	II	5 (12.8)	7 (17.9)	12 (30.8)	0.378
Post prostatectomy UTI	II	8 (20.5)	2 (5.1)	10 (25.6)	0.044
Secondary hemorrhage	II	4 (10.3)	1 (2.6)	5 (12.8)	0.18
Surgical site infection	IIIa	3 (7.7)	1 (2.6)	4 (10.3)	0.308
Persistent suprapubic fistula	IIIa	3 (7.7)	-	3 (7.7)	0.12
Delirium	II	-	2 (5.1)	2 (5.1)	0.247
Left ventricular failure	IVa	-	1 (2.6)	1 (2.6)	0.5
Cardiac arrhythmia	IVa	-	1 (2.6)	1 (2.6)	0.5
Septicemia	II	1 (2.6)	-	1 (2.6)	0.5
Total		24 (61.5)	15 (38.5)	39 (100)

LUTS: Lower urinary tract symptoms; UTI: Urinary tract infection.